| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/24/2010 | US20100158928 Immune response modifier compositions and methods |
| 06/24/2010 | US20100155714 Organic electroluminescent device |
| 06/24/2010 | US20100155713 Metal complex compound and organic electroluminescent device using same |
| 06/24/2010 | US20100155706 Material for organic photoelectric device including electron transporting unit and hole transporting unit, and organic photoelectric device including the same |
| 06/24/2010 | CA2747677A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
| 06/24/2010 | CA2747252A1 Pyrazine derivatives useful as inhibitors of atr kinase |
| 06/24/2010 | CA2747035A1 Tetrazole substituted anthranilic acid amides as pesticides |
| 06/24/2010 | CA2745297A1 Pyrimidin-2-ylamino derivatives and their use to treat inflammation |
| 06/24/2010 | CA2744935A1 New compounds |
| 06/23/2010 | EP2199282A1 Amide compound |
| 06/23/2010 | EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors |
| 06/23/2010 | EP2197875A1 Diacylglycerol acyltransferase inhibitors |
| 06/23/2010 | EP2197874A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use |
| 06/23/2010 | EP2197873A1 Compounds and compositions as modulators of gpr119 activity |
| 06/23/2010 | EP2197872A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases |
| 06/23/2010 | EP2197858A2 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same |
| 06/23/2010 | EP2197854A1 A new class of histone deacetylase inhibitors |
| 06/23/2010 | EP2197853A1 Insecticidal pyrimidinyl aryl hydrazones |
| 06/23/2010 | EP2197852A1 Spiro-condensed imidazolone derivatives inhibiting the glycine transporter |
| 06/23/2010 | EP2197849A1 N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators |
| 06/23/2010 | EP2197843A1 Piperidine derivatives as agonists of muscarinic receptors |
| 06/23/2010 | EP2197551A1 Soluble guanylate cyclase activators |
| 06/23/2010 | EP2197280A2 Pyrazole compounds for controlling invertebrate pests |
| 06/23/2010 | EP1928857B1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives |
| 06/23/2010 | EP1594859B1 Indazolamides with analgesic activity |
| 06/23/2010 | CN1926113B Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors |
| 06/23/2010 | CN1909907B Quinoline derivatives and use thereof for preparing mycobacterial inhibitors |
| 06/23/2010 | CN1906173B Protein modifier production inhibitor |
| 06/23/2010 | CN1906155B Novel hydroxamic acid ester derivant and pharmaceutical use thereof |
| 06/23/2010 | CN1835751B Therapeutic agents useful for treating pain |
| 06/23/2010 | CN1821236B Therapeutic heterocyclic compounds |
| 06/23/2010 | CN101754963A spirocyclopropyl piperidine derivatives |
| 06/23/2010 | CN101754962A N-azacyclic substituted pyrrole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 for the treatment of diabetes and metabolic disorders |
| 06/23/2010 | CN101754961A Pyrimidinone derivatives and methods of use thereof |
| 06/23/2010 | CN101754957A Novel heterocyclyl compounds and their use as chemokine antagonists |
| 06/23/2010 | CN101747321A Indole-3-benzylamine derivative, preparation method and application |
| 06/23/2010 | CN101747320A Dialdehyde-built disinsection activity-having nitrogen or oxygen-containing heterocyclic compound and preparation method |
| 06/23/2010 | CN101747319A Method for preparing imidacloprid |
| 06/23/2010 | CN101747318A 1-(3,5-dichloro-pyridyl)-1H-5-pyrazole carboxylic acid ester compound |
| 06/23/2010 | CN101747256A Blue color emitting compound and organic light emitting diode comprising the same |
| 06/23/2010 | CN101747254A Substituent indole compound and application thereof |
| 06/23/2010 | CN101747253A Trisubstituted chiral lactam derivative and preparation method and application thereof |
| 06/23/2010 | CN101274930B 1-(8-chinoline)-3(2-pyridine)-triazene, preparation thereof and application thereof |
| 06/23/2010 | CN101143862B Ionic compound containing chiral amine-thiourea (urea) and its preparation method and application |
| 06/23/2010 | CN101020659B 9-aminoalkylamido-1-azabenznthrone derivative and its synthesis and application |
| 06/22/2010 | US7741493 4,5-diphenyl-2-amino-4,5-dihydro-imidazole derivatives; antiinflammatory agent, neurodegenerative diseases; inflammatory bowel disease, rheumatoid arthritis and diseases associated with central nervous system, such as Alzheimer's disease |
| 06/22/2010 | US7741485 3-[4-Chloro-2-fluoro-5-{[isopropyl(methyl)amino]carbonylaminosulfonyl}phenyl]-1-methyl-2,4-dioxo-6-trifluoromethyl-1,2,3,4-tetrahydropyrimidine; crop protection agent |
| 06/22/2010 | US7741342 Water-soluble thalidomine derivatives |
| 06/22/2010 | US7741341 Benzimidazole-derivatives as factor Xa inhibitors |
| 06/22/2010 | US7741339 Fab I inhibitors |
| 06/22/2010 | US7741336 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer |
| 06/22/2010 | US7741332 Brain and nervous system disorders such as mood disorders or urinary incontinence, pain, anxiety, hearing loss; 2-(carbonylamino)-1,1-dioxo-1H-benzo[1,2,4]thiadiazines, 4-(oxo or thiooxo)-3-(carbonylamino)-quinazolines, and 1-(oxo or thiooxo)-2-(carbonylamino)-1,2-dihydroisoquinolines |
| 06/22/2010 | US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 06/22/2010 | US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds |
| 06/22/2010 | US7741327 Pyrrolidinone glucokinase activators |
| 06/22/2010 | US7741326 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands |
| 06/22/2010 | US7741322 Isoquinolinone potassium channel inhibitors |
| 06/22/2010 | US7741316 Pharmacological uses of azetidine derivatives |
| 06/22/2010 | US7741314 anticarcinogenic agent; arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte; inhibiting adipocyte differentiation and stearoyl CoA desaturase (SCD-1) gene transcription; skin disorder, psoriasis, obesity, antiinflammatory agent |
| 06/22/2010 | US7741313 administering 17(E)-1 alpha ,25-dihydroxy-17(20)-dehydro-2-methylene-19-nor-vitamin D3, for the treatment of acne, obesity, hypertension, cancer and skin diseases |
| 06/22/2010 | CA2579915C Indole derivatives and their use as inhibitors of p53-mdm2 interaction |
| 06/22/2010 | CA2549672C Antineutrophilia agent using 3(2h)-pyridazinone compounds |
| 06/22/2010 | CA2462149C Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 06/22/2010 | CA2444489C Benzimidazolone compounds |
| 06/22/2010 | CA2444198C Nociceptin analogs |
| 06/22/2010 | CA2441398C Lipid lowering biphenylcarboxamides |
| 06/22/2010 | CA2420996C Substituted heterocyclic compounds for treating multidrug resistance |
| 06/22/2010 | CA2412718C Viral polymerase inhibitors |
| 06/22/2010 | CA2398988C Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient |
| 06/22/2010 | CA2233550C Symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 06/17/2010 | WO2010068806A1 Amide derivatives as btk inhibitors in the treatment of allergic, autoimmune and inflammatory disorders as well as cancer |
| 06/17/2010 | WO2010068788A1 Heterocyclic amides as btk inhibitors |
| 06/17/2010 | WO2010068663A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2 |
| 06/17/2010 | WO2010068452A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 06/17/2010 | WO2010068242A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 06/17/2010 | WO2010068172A1 A new process for preparing 4- [4-methyl-5- (cl- 10alkylthio/c5-10aryl-cl-6alkylthio) -4h-1, 2, 4-triazol-3- yl] pyridines. |
| 06/17/2010 | WO2010067130A1 P38 map kinase inhibitors |
| 06/17/2010 | WO2010067085A2 Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-υ-carboline and analogues and intermediates |
| 06/17/2010 | WO2010067067A1 Compounds for treating cancer |
| 06/17/2010 | WO2010066709A1 Novel pyridinyl acrylamide derivatives |
| 06/17/2010 | WO2010066668A1 Process for manufacturing 5-formyl-pyridine-2,3-dicarboxylic acid esters |
| 06/17/2010 | WO2010066380A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes |
| 06/17/2010 | WO2010066028A1 3,4 - substituted piperidine derivatives as renin inhibitors |
| 06/17/2010 | WO2010025451A3 5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals |
| 06/17/2010 | WO2010025436A3 Nitrogen and sulfur-containing heterocycle derivatives |
| 06/17/2010 | WO2010022055A3 1, 3, 5 -triaz ine derivatives useful in the treatment of chronic pain disorders |
| 06/17/2010 | WO2010009402A9 Nilotinib intermediates and preparation thereof |
| 06/17/2010 | WO2010007116A3 Pyridons as pdk1 inhibitors |
| 06/17/2010 | US20100152465 Functionalized Ionic Liquids, and Methods of Use Thereof |
| 06/17/2010 | US20100152450 Nicotinic acetylcholine receptor ligands and the uses thereof |
| 06/17/2010 | US20100152445 Inhibitors of Diacylglycerol Acyltransferase |
| 06/17/2010 | US20100152443 Pyrazole derivative, intermediate therefor, processes for producing these, and herbicide containing these as active ingredient |
| 06/17/2010 | US20100152442 4-anilino quinazoline derivatives as antiproliferative agents |
| 06/17/2010 | US20100152439 Production method |
| 06/17/2010 | US20100152248 Ischemic disorder or disease inhibitors |
| 06/17/2010 | US20100152247 medicament for treating schizophrenia comprising cilostazol |
| 06/17/2010 | US20100152237 Bis-pyrindino containing compounds for the use in the treatment of cns pathologies |
| 06/17/2010 | US20100152228 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders |
| 06/17/2010 | US20100152219 Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
| 06/17/2010 | US20100152207 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |